C2N Diagnostics, InterVivo Solutions, and inviCRO Announce Formation of Pre …

Published January 3, 2013

C2N Diagnostics, InterVivo Solutions, and inviCRO Announce Formation of Pre …

Filed under: drug treatment programs maryland

Ultimately, the work from this collaboration intends to improve the translatability of Alzheimer's preclinical drug development to human drug development. … LLC (www.c2ndiagnostics.com) formed in late 2007 by scientific co-founders Drs. David …
Read more on PharmiWeb.com (press release)

US drug shortage linked to patient relapses

Filed under: drug treatment programs maryland

Estimated two-year cancer-free survival for patients enrolled in the study fell from 88 to 75 percent after the drug cyclophosphamide was substituted for mechlorethamine for treatment of patients with intermediate- or high-risk Hodgkin lymphoma. The …
Read more on Newnan Times-Herald

US FDA nod for Glenmark Pharmaceuticals' anti-diarrhoea drug

Filed under: drug treatment programs maryland

The drug, Crofelemer 125 mg, is aimed at treating diarrhoea in patients with HIV/AIDS and on anti-retroviral therapy. The original compound … In a press statement, Glenn Saldanha, Glenmark's Chairman and MD said: "This is a significant approval …
Read more on Business Today